Lafrid Maria, Bahadi Abdelaali, Labioui Narjiss, Hanine Ismail, Laasli Hajar, Mponguili Theresia Peya, Hallak Mohammed, Benbria Sanae, Kabbaj Driss El
Military Teaching Hospital Mohammed Vth, Nephrology, Dialysis and Renal Transplant Department, Rabat, Morocco
University Mohammed Vth, Department of nephrology, Rabat, Morocco
Nephrol Ther. 2025 May 21;21(2):1-10. doi: 10.1684/ndt.2025.119.
Peritoneal dialysis (PD) is an effective treatment option for patients with kidney failure and offers them a better quality of life. Despite its advantages, PD remains underutilized, particularly in Morocco. The aim of our study was to evaluate the impact of catheter placement by nephrologists on the number of incident PD patients, compare the success rates of this technique with those of surgical placement, and assess the short- and long-term complications associated with the two approaches.
This was a single-center retrospective study including 69 PD patients, conducted from January 2008 to December 2022.
A total of 28 patients received PD catheter placement by nephrologists (Group A), while 41 underwent the procedure performed by urologists (Group B). Since the introduction of nephrologist-led catheter placement, the incidence of patients starting PD significantly increased, with a growth rate of over 100% every two years. The waiting time for catheter placement was significantly shorter in Group A (5 days versus 20 days; p < 0.001). No significant difference was observed in the incidence of short-term mechanical and infectious complications between the two groups. Although univariable analysis revealed a higher incidence of long-term mechanical and infectious complications in Group B compared to group A, this difference was not statistically significant in multivariable analysis (p > 0.05). The success rate of PD catheter placement in Group A was 92.85%, while it was 97.56% in Group B. The one-year catheter survival rate was significantly higher in Group B than in Group A (100% versus 75%; p = 0.031), and mean catheter survival was significantly longer in Group B (17 months versus 11 months; p = 0.026).
PD catheter placement by nephrologists proved to be a safe and effective approach.
腹膜透析（PD）是肾衰竭患者的一种有效治疗选择，能为他们提供更好的生活质量。尽管有这些优点，但PD的使用率仍然较低，尤其是在摩洛哥。我们研究的目的是评估肾病学家进行导管置入对新发PD患者数量的影响，将该技术的成功率与手术置入的成功率进行比较，并评估两种方法相关的短期和长期并发症。
这是一项单中心回顾性研究，纳入了2008年1月至2022年12月期间的69例PD患者。
共有28例患者由肾病学家进行了PD导管置入（A组），而41例患者由泌尿科医生进行了该操作（B组）。自引入由肾病学家主导的导管置入以来，开始进行PD的患者发病率显著增加，每两年增长率超过100%。A组导管置入的等待时间明显更短（5天对20天；p<0.001）。两组之间短期机械和感染并发症的发生率没有显著差异。尽管单变量分析显示B组长期机械和感染并发症的发生率高于A组，但在多变量分析中这种差异没有统计学意义（p>0.05）。A组PD导管置入的成功率为92.85%，而B组为97.56%。B组的一年导管生存率显著高于A组（100%对75%；p=0.031），B组的平均导管生存时间显著更长（17个月对11个月；p=0.026）。
肾病学家进行PD导管置入被证明是一种安全有效的方法。
Zotero 插件